CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 81360-81780 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T661","span":{"begin":0,"end":420},"obj":"Sentence"},{"id":"T11486","span":{"begin":0,"end":420},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Chloramphenicol's loss of favour began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anaemia, reversible on cessation of therapy, and an irreversible, 'idiosyncratic' aplastic anaemia, which had an incidence of approximately 1 case per 30,000 courses of therapy, a high case fatality rate, and no correlation with the or duration of treatment."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T219","span":{"begin":0,"end":420},"obj":"Sentence"}],"text":"Chloramphenicol's loss of favour began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anaemia, reversible on cessation of therapy, and an irreversible, 'idiosyncratic' aplastic anaemia, which had an incidence of approximately 1 case per 30,000 courses of therapy, a high case fatality rate, and no correlation with the or duration of treatment."}

{"project":"Epistemic_Statements","denotations":[{"id":"T159","span":{"begin":0,"end":420},"obj":"Epistemic_statement"}],"text":"Chloramphenicol's loss of favour began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anaemia, reversible on cessation of therapy, and an irreversible, 'idiosyncratic' aplastic anaemia, which had an incidence of approximately 1 case per 30,000 courses of therapy, a high case fatality rate, and no correlation with the or duration of treatment."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T69","span":{"begin":162,"end":169},"obj":"Phenotype"},{"id":"T70","span":{"begin":244,"end":260},"obj":"Phenotype"}],"attributes":[{"id":"A69","pred":"hp_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/HP_0001903"},{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0001915"}],"text":"Chloramphenicol's loss of favour began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anaemia, reversible on cessation of therapy, and an irreversible, 'idiosyncratic' aplastic anaemia, which had an incidence of approximately 1 case per 30,000 courses of therapy, a high case fatality rate, and no correlation with the or duration of treatment."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T280","span":{"begin":162,"end":169},"obj":"Disease"},{"id":"T281","span":{"begin":253,"end":260},"obj":"Disease"},{"id":"T278","span":{"begin":162,"end":169},"obj":"Disease"},{"id":"T43240","span":{"begin":253,"end":260},"obj":"Disease"}],"attributes":[{"id":"A280","pred":"mondo_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A281","pred":"mondo_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A86182","pred":"mondo_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"},{"id":"A68916","pred":"mondo_id","subj":"T43240","obj":"http://purl.obolibrary.org/obo/MONDO_0002280"}],"text":"Chloramphenicol's loss of favour began in the 1960s, when it was shown to have two distinct toxic effects on hematopoiesis: a frequently observed, dose-dependent anaemia, reversible on cessation of therapy, and an irreversible, 'idiosyncratic' aplastic anaemia, which had an incidence of approximately 1 case per 30,000 courses of therapy, a high case fatality rate, and no correlation with the or duration of treatment."}